Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy - achieving global consensus and visibility for cellular host-directed therapies
| Image |  |
|---|---|
| Description | scientific article published on 17 May 2020 |
| Author/s |
author: Laurence Zitvogel Giuseppe Ippolito Esam I Azhar Alimuddin Zumla |
| Publication date | May 17, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |